|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61P 31/14 | (2006.01) |
| A61P 31/20 | (2006.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61K 39/42 | (2006.01) | ||
| C07K 16/08 | (2006.01) | ||
| C07K 16/10 | (2006.01) |
| (11) | Number of the document | 3359564 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16779075.7 |
| Date of filing the European patent application | 2016-10-07 | |
| (97) | Date of publication of the European application | 2018-08-15 |
| (45) | Date of publication and mention of the grant of the patent | 2020-06-03 |
| (46) | Date of publication of the claims translation | 2020-10-26 |
| (86) | Number | PCT/EP2016/074114 |
| Date | 2016-10-07 |
| (87) | Number | WO 2017/060504 |
| Date | 2017-04-13 |
| (30) | Number | Date | Country code |
| PCT/EP2015/0019 | 2015-10-07 | WO |
| (72) |
CORTI, Davide, CH
|
| (73) |
Humabs Biomed SA,
Via dei Gaggini, 3, 6500 Bellinzona,
CH
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Antikūnai, kurie stipriai neutralizuoja hepatito B virusą, ir jų panaudojimas |
| ANTIBODIES THAT POTENTLY NEUTRALIZE HEPATITIS B VIRUS AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2025-09-18 | 10 | 231.00 EUR |
| 2026-10-07 |